• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The immunopathogenesis and the regulation of hepatic lesions in murine model of primary biliary cirrhosis.

Research Project

Project/Area Number 08457160
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionUniversity of Tsukuba

Principal Investigator

TANAKA Naomi  Institute of Clinical Medicine, University of Tsukuba Professor, 臨床医学系, 教授 (60111530)

Co-Investigator(Kenkyū-buntansha) MATSUZAKI Yasushi  Institute of Clinical Medicine, University of Tsukuba, 臨床医学系, 講師 (50209532)
FUHJIWARA Michio  University of Tokyo (80012722)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥7,000,000 (Direct Cost: ¥7,000,000)
Fiscal Year 1997: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 1996: ¥5,000,000 (Direct Cost: ¥5,000,000)
Keywordsprimary biliary cirrhosis / graft versus host reaction / helper T cell subset / cytokine / interleukin-l0 / Interferon-gamma / adhesion molecule / VLA-4 / Th2
Research Abstract

We have previously reported that CD4^+ T cells induced primary biliary cirrhosis (PBC) Iike hepatic lesions in mice with graft-versus-host reaction (GVHR) due to major histocompatibility complex (MHC) class [[disparity. In this srudy, to ciarify the relationship between the cytokine profile produced by CD4^+ T cells and the formation of hepatic lesions. we sorted CD4^+ T cells from the liver using flowcytometer and examined their cytokine mRNA expressions at various time points after GVHR induction. Furthermore, we examined wheather Th1/Th2 balance might change during the suppression of lesions by antibodies against adhesion molecules. l) Histologically, the infiltration of CD4^+ T cells around the bile ducts was observed from day 5, and the lesions deteriorated gradually untii day 14. On day 14, CD8^-, B220^+ and Mac-l^+ cells, as well as CD4^+ T cells around the bile ducts were seen. In the liver infiltrating CD4^- T cells. the expression level of Th1 cytokine IFN-gamma mRNA was obse … More rved to increae at an early phase day 3, whereas that of Th2 cytokine IL-l0 mRNA was elevated at a later phase day 14. Serum levels of AMA on day 14 were significantly higher than that on day 5.2) H.E.staining showed the grade of portal cellular infiltration both in groups administered anti-VLA-4 antibodies and anti-VCAM-1 antibodies and only anti-VLA-4 antibodies were significantly suppressed compared to the control adminstered normal rat lgG.The induction of GVHR and the elevation of AMA were not alterd in these groups by administering monoclonal antibodies. The expressions of IL-2, IFNgamma, IL-4 and IL-l0 mRNA were not changed in these groups. Immunohistochemically, CD4, CD8, B220 or Mac-1 positive cells were detected in these groups. The elevation of IFN-gamma mRNA expression in the early phase before the appearance of NSDC lesions suggest that Th1 cells may be related to the pathogenesis of PBC in this model. Delayd expression of IL-l0 mRNA may reflect the suppression of cytokine production by Th1 cells in the liver. Moreover, the portal cellular infiltration in PBC animal model Is reduced by the administration of antibodies against VLA-4. However, cytokine profile of liver infiltrating Thyl.2^+CD4^+ lymphocytes and the composition of infiltrating cells were not changed. These results suggest that the administration of antibodies against adhision molecule may suppress PBC Iike lesions without Th1/Th2 balance. Less

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Kimura, Takeshi.: "Monoclonal antibody against lymp-hocyte function-associate antigene inhi-bits the formation of primary biliary c-irrhosis-like lesion induced by murine graft-versus-host reation." Hepatology. 24(4). 888-894 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kimura T,Suzuki K,Inada S,Hayashi A,Saito H,Miyai T,Ohsugi Y,Matsuzaki Y,Tanaka N,Osuga T,Fujiwara M: "Indication of autoimmune disease by graft-versus-host reaction across MHC class II difference : modification of the lesions in IL-6 transgenic mice" Clin Exp Immunol. 95 (4). 525-529 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kimura T,Enosawa S,Kamada N,Kobayashi E,Toyama N,Doy M.Matsuzaki Y,Tanaka N,Osuga T: "Evidence that the elevation of soluble MHC class I antigens in the serum precedes the onset of graft-versus-host disease and is correlated with the severity of the disease in rats" Transplant Immunology. 3. 299-304 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kimura T,Suzuki K,Inada S,Hayashi A,Isobe M,Matsuzaki Y,Tanaka N,Osuga T,Fujiwara M: "Monoclonal antibody against lymphocyte function-associated antigen! inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction" Hepatology. 24 (4). 888-894 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kimura Takeshi: "monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesion induced by murine graft-versus-host reaction" Hepatology. 24(4). 888-894 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Takeshi Kimura: "nrudomal antibodty ageinst lymphocytedunction associcted antigen I inhihit the do motion of PBC Ute lesicns induced by muine GVHR" Hepatology. 24. 888-894 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Shinichi ltoh: "Delayed expression of Thelpos 2 type cytokine mRNA of Vosl indilslcting iymphocytes in muline model of PBC" Gastboenterolegy. 110. A1219 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 田中 直見: "原発性胆汁性肝硬変" 治療. 78. 848-850 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 松崎 靖司: "原発性胆汁性肝硬変の薬物治療" 消化器診療プラクティス14、自己免疫性肝症炎. 169-174 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi